The research team cultivates "mini brains" with stem cell technology to evaluate the patients’ brain reactions to potential drug candidates in developing novel AD treatments. (IMAGE)

Hong Kong University of Science and Technology

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.